Subscribe
ueli-giezendanner-shutterstock-com
Ueli Giezendanner / Shutterstock.com
2 August 2016Big Pharma

NHS should finance HIV treatment PrEP, English High Court rules

The English High Court has today said that National Health Service (NHS) England should finance an important therapy used to treat patients suffering from HIV.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
NHS v Servier: unlawful means tort claim fails, but the long-running saga continues
17 August 2021   The latest episode in the long-running dispute between the NHS and French pharmaceutical company Servier has been marked by a UK Supreme Court judgment of July 2, 2021 on Servier’s application to strike out the NHS’s unlawful means tort claim.
Big Pharma
NHS criticised over HIV drug wait
2 June 2016   National Health Service England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Europe
NHS v Servier: unlawful means tort claim fails, but the long-running saga continues
17 August 2021   The latest episode in the long-running dispute between the NHS and French pharmaceutical company Servier has been marked by a UK Supreme Court judgment of July 2, 2021 on Servier’s application to strike out the NHS’s unlawful means tort claim.
Big Pharma
NHS criticised over HIV drug wait
2 June 2016   National Health Service England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis.

More on this story

Europe
NHS v Servier: unlawful means tort claim fails, but the long-running saga continues
17 August 2021   The latest episode in the long-running dispute between the NHS and French pharmaceutical company Servier has been marked by a UK Supreme Court judgment of July 2, 2021 on Servier’s application to strike out the NHS’s unlawful means tort claim.
Big Pharma
NHS criticised over HIV drug wait
2 June 2016   National Health Service England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility